DNMT1: Difference between revisions

Revision as of 12:36, 31 December 2024

DNMT1

DNMT1, or DNA (cytosine-5)-methyltransferase 1, is an enzyme that plays a crucial role in the maintenance of DNA methylation patterns in mammalian cells. DNA methylation is an essential epigenetic modification involved in regulating gene expression, genomic stability, and cellular differentiation.

Function

DNMT1 is primarily responsible for copying methylation patterns from the parental DNA strand to the daughter strand during DNA replication. This process ensures that the methylation pattern is faithfully inherited by daughter cells, maintaining the epigenetic state of the genome across cell divisions.

Structure

DNMT1 is a large protein composed of several functional domains:

The N-terminal regulatory domain, which includes a replication foci targeting sequence (RFTS) that localizes DNMT1 to replication foci during S phase.
The CXXC domain, which binds to unmethylated CpG dinucleotides and is involved in the recognition of DNA substrates.
The BAH (bromo-adjacent homology) domains, which are thought to mediate protein-protein interactions.
The C-terminal catalytic domain, which contains the active site responsible for the transfer of a methyl group from S-adenosylmethionine (SAM) to the 5-carbon of cytosine residues in DNA.

Role in Development and Disease

DNMT1 is essential for normal development and cellular differentiation. Aberrant DNA methylation patterns, often involving DNMT1, have been implicated in various diseases, including cancer, neurological disorders, and imprinting diseases.

Cancer

In cancer, DNMT1 is frequently overexpressed, leading to hypermethylation of tumor suppressor genes and contributing to oncogenesis. Inhibitors of DNMT1, such as 5-azacytidine, are used as therapeutic agents in certain types of cancer to reactivate silenced genes.

Neurological Disorders

Altered DNMT1 activity has been associated with neurological disorders such as Rett syndrome and ICF syndrome (Immunodeficiency, Centromeric instability, and Facial anomalies syndrome). These conditions are characterized by defects in DNA methylation and chromatin structure.

Imprinting Disorders

DNMT1 is also involved in the maintenance of genomic imprinting, a process where certain genes are expressed in a parent-of-origin-specific manner. Disruption of DNMT1 function can lead to imprinting disorders such as Prader-Willi syndrome and Angelman syndrome.

Regulation

The activity of DNMT1 is tightly regulated at multiple levels, including transcriptional control, post-translational modifications, and interactions with other proteins. For example, DNMT1 is phosphorylated, acetylated, and ubiquitinated, which can affect its stability, localization, and activity.

Research and Therapeutic Implications

Understanding the precise mechanisms of DNMT1 function and regulation is an active area of research, with significant implications for the development of epigenetic therapies. Targeting DNMT1 and other components of the DNA methylation machinery holds promise for treating a variety of diseases with epigenetic underpinnings.

@@ Line 1: / Line 1: @@
-DNMT1 (DNA methyltransferase 1) is an enzyme that plays a crucial role in the process of DNA methylation. DNA methylation is a chemical modification of DNA that involves the addition of a methyl group to the cytosine residue of a DNA molecule. This modification is important for regulating gene expression and maintaining genomic stability.
+DNMT1
-== Function ==
+DNMT1, or DNA (cytosine-5)-methyltransferase 1, is an enzyme that plays a crucial role in the maintenance of DNA methylation patterns in mammalian cells. DNA methylation is an essential epigenetic modification involved in regulating gene expression, genomic stability, and cellular differentiation.
-DNMT1 is primarily responsible for maintaining DNA methylation patterns during DNA replication. It recognizes hemi-methylated DNA, which is DNA that has one methylated and one unmethylated strand, and adds a methyl group to the unmethylated strand. This ensures that the newly synthesized DNA strand is methylated in the same pattern as the original DNA strand.
-== Role in Gene Regulation ==
+==Function==
-DNA methylation is an epigenetic modification that can influence gene expression. DNMT1 plays a critical role in this process by adding methyl groups to specific regions of the DNA molecule, known as CpG islands. CpG islands are regions of DNA that contain a high density of cytosine-guanine dinucleotides (CpG sites). Methylation of CpG islands is often associated with gene silencing, as it can prevent the binding of transcription factors and other regulatory proteins to the DNA.
+DNMT1 is primarily responsible for copying methylation patterns from the parental DNA strand to the daughter strand during DNA replication. This process ensures that the methylation pattern is faithfully inherited by daughter cells, maintaining the epigenetic state of the genome across cell divisions.
-== Importance in Development and Disease ==
+==Structure==
-Proper regulation of DNA methylation is essential for normal development and cellular function. DNMT1 is particularly important during embryonic development, as it helps establish and maintain cell identity by regulating gene expression patterns. Mutations or dysregulation of DNMT1 can lead to developmental abnormalities and diseases, including cancer.
+DNMT1 is a large protein composed of several functional domains:
+* The N-terminal regulatory domain, which includes a replication foci targeting sequence (RFTS) that localizes DNMT1 to replication foci during S phase.
+* The CXXC domain, which binds to unmethylated CpG dinucleotides and is involved in the recognition of DNA substrates.
+* The BAH (bromo-adjacent homology) domains, which are thought to mediate protein-protein interactions.
+* The C-terminal catalytic domain, which contains the active site responsible for the transfer of a methyl group from S-adenosylmethionine (SAM) to the 5-carbon of cytosine residues in DNA.
-== Clinical Significance ==
+==Role in Development and Disease==
-DNMT1 has been implicated in various types of cancer, including colorectal cancer, lung cancer, and leukemia. Aberrant DNA methylation patterns, often resulting from dysregulation of DNMT1, can lead to the silencing of tumor suppressor genes and the activation of oncogenes. Targeting DNMT1 and other DNA methyltransferases has emerged as a potential therapeutic strategy for cancer treatment.
+DNMT1 is essential for normal development and cellular differentiation. Aberrant DNA methylation patterns, often involving DNMT1, have been implicated in various diseases, including cancer, neurological disorders, and imprinting diseases.
-== References ==
+===Cancer===
-<references>
+In cancer, DNMT1 is frequently overexpressed, leading to hypermethylation of tumor suppressor genes and contributing to oncogenesis. Inhibitors of DNMT1, such as 5-azacytidine, are used as therapeutic agents in certain types of cancer to reactivate silenced genes.
-  <ref>[[DNMT1: a key enzyme in DNA methylation]]</ref>
-  <ref>[[DNA methylation and cancer]]</ref>
-  <ref>[[Epigenetic regulation of gene expression]]</ref>
-</references>
-== See Also ==
+===Neurological Disorders===
+Altered DNMT1 activity has been associated with neurological disorders such as Rett syndrome and ICF syndrome (Immunodeficiency, Centromeric instability, and Facial anomalies syndrome). These conditions are characterized by defects in DNA methylation and chromatin structure.
+===Imprinting Disorders===
+DNMT1 is also involved in the maintenance of genomic imprinting, a process where certain genes are expressed in a parent-of-origin-specific manner. Disruption of DNMT1 function can lead to imprinting disorders such as Prader-Willi syndrome and Angelman syndrome.
+==Regulation==
+The activity of DNMT1 is tightly regulated at multiple levels, including transcriptional control, post-translational modifications, and interactions with other proteins. For example, DNMT1 is phosphorylated, acetylated, and ubiquitinated, which can affect its stability, localization, and activity.
+==Research and Therapeutic Implications==
+Understanding the precise mechanisms of DNMT1 function and regulation is an active area of research, with significant implications for the development of epigenetic therapies. Targeting DNMT1 and other components of the DNA methylation machinery holds promise for treating a variety of diseases with epigenetic underpinnings.
+==See Also==
 * [[DNA methylation]]
 * [[Epigenetics]]
 * [[Gene expression]]
-* [[CpG islands]]
+* [[Cancer epigenetics]]
+* [[Rett syndrome]]
+* [[Imprinting (genetics)]]
+{{Enzyme-stub}}
+{{Epigenetics}}
 [[Category:Enzymes]]
 [[Category:Epigenetics]]
-[[Category:Genetics]]
+[[Category:DNA methylation]]
-[[Category:DNA]]
+[[Category:Human proteins]]
-[[Category:Cell biology]]
-[[Category:Developmental biology]]
-[[Category:Cancer research]]
-[[Category:Medical research]]
-[[Category:Biological processes]]
-[[Category:Gene regulation]]
-[[Category:Genomic stability]]
-[[Category:Oncology]]
-[[Category:Therapeutic targets]]